A B S T R A C T Mechanisms responsible for alcohol-induced heart muscle disease have been difficult to elucidate partly because of previously obscure, demonstrable cardiac metabolism of ethanol. Recently, fatty acid ethyl esters were identified in our laboratory and found to be myocardial metabolites of ethanol. In the present study, they have been shown to induce mitochondrial dysfunction. Incubation of isolated myocardial mitochondria with fatty acid ethyl esters led to a concentration-dependent reduction of the respiratory control ratio index of coupling of oxidative phosphorylation and decrement of maximal rate of oxygen consumption. Furthermore, fatty acid ethyl esters were demonstrated to bind to mitochondria in vitro, and, importantly, 72% of intracellularly synthesized ethyl esters were found to bind to mitochondria isolated from intact tissue incubated with ethanol. Protein binding of fatty acid ethyl esters was markedly less than that of fatty acids. Because uncoupling of mitochondrial oxidative phosphorylation correlated with the cleavage of fatty acid ethyl ester shown to be initially bound to mitochondria, with resultant generation of fatty acid, a potent uncoupler, in a locus in or near the mitochondrial membrane, fatty acid ethyl esters may contribute to a potentially toxic shuttle for fatty acid with transport from physiological intracellular binding sites to the mitochondrial membrane; direct effects of fatty acid ethyl esters may also be deleterious. Operation of this shuttle as a result of ethanol ingestion and subsequent accumulation of fatty acid ethyl esters may account for the impaired mitochondrial function and inefficient energy production associated with toxic effects of ethanol on the heart.
INTRODUCTION
Alcohol-induced heart disease is a common disorder afflicting more than 200,000 Americans (1). Despite its prevalence, its well-characterized ethanol-induced depression of myocardial contractility (2-4) and arrhythmias (5) , and changes that it produces in myocardial lipid composition (6) (7) (8) , the pathophysiology of this disorder has remained obscure. The apparent lack of demonstrable cardiac metabolism of ethanol (6, 9) has made it difficult to elucidate a direct link between exposure to alcohol and the metabolic changes noted.
It has been known since 1917 that even moderate consumption of alcohol increases the basal metabolic rate of some subjects, which is reflected by a 5-7% increase in total body oxygen consumption (10) . Such changes could be due to alterations in mitochondrial function. Consumption of alcohol over several weeks leads to gross morphological changes in heart mitochondria in laboratory animals (11, 12) and human subjects (13, 14) . Impairment of mitochondrial function has been noted as well and it includes diminished phosphate/oxygen ratios (P/O)' and respiratory control ratios (15) (16) (17) (18) ; these are changes that do not occur after exposure of mitochondria to ethanol in vitro.
Recent work from our laboratory has identified a class of metabolites of ethanol metabolism that are formed in isolated, perfused rabbit hearts (19) . The products, fatty acid ethyl esters, arise principally through a soluble esterase-catalyzed esterification of ethanol with free fatty acid (20) . The reaction is promninent at physiological concentrations of each substrate. Subsequently, fatty acid ethyl esters in concentrations as high as 115 ,uM were identified in hearts obtained at autopsy from patients either acutely intoxicated at the time of death or chronically exposed to alcohol (21) .
The present study was undertaken to determine whether fatty acid ethyl esters could be the metabolic link between ethanol consumption and alcohol-induced mitochondrial dysfunction. Results with isolated heart muscle mitochondria from rabbits indicate that fatty acid ethyl esters may initiate a toxic fatty acid shuttle which leads to impairment and uncoupling of oxidative phosphorylation.
METHODS
All reagents were of the highest grade commercially available. Lipid solvents were distilled before use. Lipids were purified by standard thin-layer chromatographic techniques (19, 20) . Radiolabeled compounds were purchased from Sigma Chemical Co., St. Louis, MO or Amersham Corp., Arlington Heights, IL. Ethyl [3H]oleate was a gift of Dr. S. Mogelson .
Preparation of mitochondria. Fresh mitochondria were prepared daily from rabbit hearts by standard methods (22) (23) (24) . Oxidative function was assessed polarographically with a polarograph (Yellow Springs Instrument Co., Yellow Springs, OH; reference 24, 25) . Rabbits were sacrificed after cervical dislocation and their hearts were removed immediately and placed in homogenizing medium (HM): 0.25 M sucrose, 10 mM EDTA, 0.1% bovine serum albumin (BSA) at 0-4°C. The preparation was completed as rapidly as possible. After the trimmed ventricles had been washed with HM, the tissue was minced with a scissors and passed through a precooled, hand-operated muscle press to give a 15% (wt/ vol) suspension which was homogenized in a Potter-Elvehjen apparatus (Fisher Scientific Co., Pittsburgh, PA) (six strokes). After filtration through cheesecloth, the suspension was centrifuged at 2,500 g for 10 min. The supernatant fat on the surface was removed with a cotton swab, the pellet discarded, and the supernatant fraction centrifuged at 9,000 g for 10 min. The resulting mitochondrial pellet was washed three times with 30 ml each of HM and repelleted at 9,000 g for 10 min. The final pellet was gently resuspended in 1 ml HM/g original wet weight of ventricle.
The mitochondrial preparation was characterized polarographically, microscopically, and enzymatically. Electron microscopy of the final mitochondrial pellet after fixation, staining, and processing as previously described (26) 15 Mmol magnesium chloride, and 20 Mmol EDTA, at pH 7.4, at a final mitochondrial protein concentration of 2 mg/ml (27) . State III respiration was initiated by addition of 700 1A of a solution of sodium malate-sodium pyruvate, pH 7, to give a final concentration of 21 mM; this was followed after 2 min by addition of ADP, 1.25 umol in a volume of 50 Ml. Recordings were performed at least in duplicate with calculations of the rates of oxygen consumption obtained from the second ADP addition. Quality of the preparation was assured by determination of respiratory control indexes and the rate of state III oxygen consumption as previously described. Preparations exhibiting coupling ratios of <4.0 or rates of maximum oxygen consumption less than 180 natoms/min per mg were not used. Over many months, mitochondrial preparations had coupling ratios of 7 to 9, maximal oxygen consumption rates of 220 natoms/min per mg, and P/O ratios of 2.7 to 3.0. The time course for uncoupling of oxidative phosphorylation that was induced by fatty acid ethyl esters was characterized under conditions in which the concentration of ethyl oleate was held constant at 100 MM (Fig. 3) . As Time course of mitochondrial uncoupling induced by ethyl oleate. The conditions are those described in the legend for Fig. 1 (Figs. 1-3 ) at concentrations of ethyl esters that are known to occur in human myocardium (21) . Uncoupling correlated with binding of ethyl oleate to mitochondria (Fig. 4) and with hydrolysis of the ester by mitochondria to form oleate (Figs. 5 and 6 ), a known uncoupler of oxidative phosphorylation (29) . Because fatty acid ethyl esters are formed in myocardium principally from nonesterified fatty acid (20) , since ethyl esters are bound less readily to protein than are nonesterified fatty acids (Fig. 7) , and because fatty acid ethyl esters synthesized in myocardial tissue slices bind substantially to mitochondria, fatty acid ethyl esters may act in a toxic fatty acid shuttle to induce mitochondrial dysfunction in vivo after prolonged alcohol abuse. A mechanism for such a shuttle is depicted in Fig. 8 .
Under physiological conditions, the amount of nonesterified fatty acid (total intracellular concentration in the range of 250-500 nmol/g [20, 30] ) that is kinetically free is probably quite small. Intracellular binding sites for nonesterified fatty acid have been identified, such as fatty acid binding protein (31) . As shown in Fig. 8 , they may protect mitochondria and other organelles from damage by maintaining the concentration of free fatty acid at low levels. However, as shown in the lower panel of Fig. 8 , after consumption of ethanol, nonesterified fatty acid becomes converted to fatty acid ethyl ester by a cytoplasmic esterase (20) . The esterified compounds can accumulate in concentrations as high as 115 uM in human myocardium (21) . Since fatty acid ethyl esters are neutral molecules, they bind less readily to proteins, such as albumin (Fig. 7) , and also possibly to fatty acid binding proteins, which bind molecules that are negatively charged at (Fig. 8) .
Mitochondria contain an enzyme that can cleave ethyl oleate to form fatty acid and ethanol (Fig. 8) . Fatty acid itself is a known inhibitor and uncoupler of mitochondrial oxidation in concentrations as low as 5 gM (29) . On the other hand, since fatty acid ethyl esters bind to mitochondria, they may, of course, directly affect mitochondrial function, especially over long intervals. Such direct modulation of function would not be unreasonable since incorporation of a neutral lipid into the mitochondrial membrane could alter its permeability to other ions that are important in oxidative phosphorylation.
Several factors may modulate fatty acid ethyl esterinduced mitochondrial damage (Fig. 8 , encircled numbers) in subjects exposed to ethanol. First, factors that regulate the equilibrium concentration of kinetically free fatty acid could be important, because enzymatic conversion to ethyl esters might be affected by them. Second, the activity of intracellular enzyme(s) that synthesize fatty acid ethyl esters may be influenced both by small molecule effectors or potentially by isoenzymes with inherent differences in catalytic properties. Third, the amount of ethanol ingested and its rate of clearance would modify the concentration of ethanol in myocardium available for esterification. Fourth, the rates at which nonesterified fatty acid is regenerated in or near the mitochondria membrane may be variable. Modification of these and other metabolic factors is probable. Thus, the overall effect on mitochondria may be different from individual to individual because of genetic or environmental factors or both. Furthermore, since alcohol abuse is chronic, metabolic insults to myocardial mitochondria may occur over long intervals. Thus, the reparative reserve of mitochondria may be critical.
For many years it has been assumed that myocardium does not metabolize ethanol (6, 9) . Thus, unlike the liver, for which at least three metabolic pathways for ethanol oxidation have been identified that are quantitatively more significant than hepatic fatty acid ethyl ester formation, it has been difficult to relate ethanol ingestion to cardiac disease because of the lack of an intermediary metabolic link. Results of our studies have demonstrated that fatty acid ethyl esters are formed in isolated, perfused hearts (19) . The existence of such compounds in biological systems has been shown previously, but a number of important points still merit consideration. The first description of fatty acid ethyl esters was made in 1963 (32) (33) , the actual extent of in vivo formation of fatty acid ethyl esters is difficult to estimate. Of interest, in another study, fatty acid ethyl esters were identified in Rhizopus arrhizus (34) , but no enzymatic pathway for their formation was identified. In vitro production of fatty acid ethyl esters was noted initially in 1973 in liver microsomes (35) and subsequently confirmed (36) . In view of the widespread use of methanol as a competing nucleophile for water in the study of numerous proteases (37) to form methyl esters, the quantitative importance of the finding that ethanol in vitro may give rise to ethyl esters is difficult to assess, especially when 40 MM palmitoyl-Coenzyme A, a supraphysiological concentration, was used in the assays. Subsequent studies in our laboratory demonstrated that fatty acid ethyl esters are indeed formed in vivo (21, 38) and that fatty acid ethyl ester synthesis uses primarily nonesterified fatty acid as a substrate (20) at their respective physiological concentrations. Purified cholesterol esterase from pancreas was demonstrated to rapidly catalyze the formation of fatty acid ethyl esters from nonesterified fatty acid and ethanol (20) . Therefore, it was hypothesized that this or a very similar enzyme catalyzed their formation in the heart. Subsequently, we purified over a 1,000-fold to near homogeneity from rabbit myocardium an enzyme that rapidly synthesizes fatty acid ethyl esters from ethanol and nonesterified fatty acid (39) . Significantly, heart is much more active than liver in overall fatty acid ethyl ester formation and accumulation (38) , while skeletal muscle is essentially inactive. Studies have also shown that fatty acid ethyl esters accumulate in human myocardium with tl/2 substantially exceeding that of ethanol itself (21, 38) . The present results indicated that fatty acid ethyl esters can induce mitochondrial dysfunction.
Mitochondrial dysfunction has been implicated strongly in the syndrome of alcohol-induced heart disease. In 1917, it was shown that oxygen consumption is increased after even moderate ingestion of ethanol in some individuals (10) . Over the past 20 yr, light and electron microscopic changes in mitochondrial structure and function have been documented in myocardium from animals (11, 12) and human subjects (13, 14) exposed to ethanol. After a lag period of ethanol exposure in vivo, mitochondria isolated from the heart exhibit impaired rates of oxygen consumption, diminished respiratory control, and reduced P/O ratios (15) (16) (17) (18) . Although such changes may regress in vivo with cessation of exposures to ethanol, reversibility is not immediate but requires up to 8 wk (17) .
The results of this study suggest that fatty acid ethyl esters, myocardial metabolites of ethanol, may contribute to the mitochondrial dysfunction associated and possibly pathogenetically involved in alcohol-induced heart disease through several potential mechanisms including induction of a toxic fatty acid shuttle in the heart.
